Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials

Overview of attention for article published in Pediatric Rheumatology, March 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

policy: 1 policy source

twitter: 2 X users

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 58 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,062 followers.

Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology – what we know and what we do not know from randomized controlled trials https://t.co/SLkgF6bhLe

26 Mar 2021

Reply Repost Favourite

My first full length publication!! 🎉🎉 Does that make me a real scientist now? 👩‍🔬 https://t.co/Neu3TIv0Eu

26 Mar 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.